老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
健康照護類股ETF-SPDR
168.35
+0.6900
0.41%
成交量:
304.92萬
成交額:
5.13億
市值:
437.15億
市盈率:
-11.84
高:
168.80
開:
167.75
低:
167.50
收:
167.66
52周最高:
176.60
52周最低:
133.73
股本:
2.60億
流通股本:
2.60億
量比:
0.80
換手率:
1.17%
股息:
2.53
股息率:
1.50%
每股收益(TTM):
-14.2170
每股收益(LYR):
-14.2170
淨資產收益率:
-9.22%
總資產收益率:
1.03%
市淨率:
1.27
市盈率(LYR):
-11.84
資料載入中...
總覽
公司
新聞資訊
公告
2070元/月,佛山這筆錢上調
珠江时报
·
09/07
醫療健康板塊動態:市場快訊匯總
投资观察
·
09/07
諾華降膽固醇藥物遭遇挫折,令人們對新興心臟病藥物的期望蒙上陰影
路透中文
·
09/07
人保健康保險大連分公司被罰27萬,涉聘任不合格人員等
蓝鲸财经
·
09/07
研究發現,美國越來越多的12歲以下兒童被開具減肥藥處方
路透中文
·
09/05
醫療健康板塊動態:市場快訊匯總
投资观察
·
09/05
丹陽家長注意!2027年度學生醫保繳費啓動
丹阳发布
·
09/04
一項針對僱主的調查預計,美國醫療保健成本將出現20多年來最大漲幅:2027年僱主提供的醫療保險成本預計將較今年上升8.2
智通财经
·
09/04
醫療板塊市場快訊:和黃醫藥與GSK達成許可協議,AstraZeneca新藥前景獲看好
投资观察
·
09/04
109億美元重磅收購Apogee(APGE.US)落地!艾伯維(ABBV.US)完成2019年以來最大併購,預計2032年起貢獻收益
智通财经
·
09/04
109億美元重磅收購Apogee(APGE.US)落地!艾伯維(ABBV.US)完成2019年以來最大併購,預計2032年起貢獻收益
智通财经
·
09/04
默沙東PD-1抑制劑可瑞達局部晚期頭頸鱗癌適應症在華獲批
格隆汇
·
09/04
醫療保健板塊市場快訊:比特幣漲勢帶動加密市場樂觀情緒,阿斯利康新藥潛力引關注
投资观察
·
09/04
醫療健康板塊市場綜述:行業動態與個股追蹤
投资观察
·
09/04
印度西普拉(Cipla)與中國齊魯製藥合作,在美國推出默克公司Keytruda的生物類似藥
路透中文
·
09/03
美國衞生與公眾服務部醫療保險和醫療補助服務中心:特朗普政府宣佈撥款1.2億美元,用於擴大印第安納州母嬰健康服務,提高初級
智通财经
·
09/03
艾伯維公布Cervino三期試驗積極頂線結果:Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期
美股速递
·
09/03
艾伯維的血液癌症藥物達到了晚期臨床試驗的目標
路透中文
·
09/03
阿斯彭預計,2027年Mounjaro在非洲的銷售額將超過1.24億美元
路透中文
·
09/03
American Healthcare REIT(AHR)宣佈完成收購八個高端養老社區 涉資近7億美元
金吾财讯
·
09/03
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/XLV/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照護類股ETF-SPDR","latestPrice":168.35,"timestamp":1789576777534,"preClose":167.66,"halted":0,"volume":3049221,"delay":0,"changeRate":0.004115471788142656,"floatShares":259665324,"shares":259665324,"eps":-14.217021,"marketStatus":"交易中","change":0.69,"latestTime":"09-16 12:39:42 EDT","open":167.75,"high":168.8,"low":167.5,"amount":513033018.84492,"amplitude":0.007754,"askPrice":168.37,"askSize":1348,"bidPrice":168.34,"bidSize":300,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":167.66,"sharesOutstanding":265215324,"nav":167.716534,"aum":43566939827.04,"dividendRate":0.015038,"bidAskSpread":0.000107,"preHourTrading":{"tag":"盘前","latestPrice":167.72,"preClose":167.66,"latestTime":"09:29 EDT","volume":2228,"amount":374170.58736,"timestamp":1789565399999,"change":0.06,"changeRate":0.000358,"amplitude":0.00679},"postHourTrading":{"tag":"盘后","latestPrice":167.9,"preClose":167.66,"latestTime":"19:48 EDT","volume":290838,"amount":48762008.102,"timestamp":1789516088152,"change":0.24,"changeRate":0.001431,"amplitude":0.001431},"volumeRatio":0.796219,"impliedVol":0.1731,"impliedVolPercentile":0.4343},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":259665324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.796219,"shares":259665324,"dividePrice":2.5317,"high":168.8,"amplitude":0.007754,"preClose":167.66,"low":167.5,"week52Low":133.725,"pbRate":"1.27","psRate":"66.37","week52High":176.595,"institutionHeld":0.7846,"latestPrice":168.35,"committee":-0.635922,"eps":-14.217021,"divideRate":0.015038,"volume":3049221,"delay":0,"ttmEps":-14.217021,"open":167.75,"prevYearClose":154.8,"prevWeekClose":165.36,"prevMonthClose":170.54,"prevQuarterClose":158.66,"fiveDayClose":166.58,"twentyDayClose":169.73,"sixtyDayClose":150.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665315217","title":"2070元/月,佛山這筆錢上調","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315217","media":"珠江时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315217?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775200,"startTime":"0","endTime":"0","summary":"随着佛山市最低工资标准9月1日失业金自待遇所属期2026年9月起上调至2070元/月。(二)享受的待遇标准1、失业保险金:按我市企业职工最低工资标准的90%按月发放,待遇所属期2026年9月起是2070元/月。大龄领金人员达到法定退休年龄时,或出现停止领取失业保险金情形的,停止享受由失业保险基金继续承担企业职工基本养老保险费。2025年2月1日及之后申请失业保险金的失业人员,按修改后的省条例执行,不再发放求职补贴。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6360828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","XBI","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175448508","title":"醫療健康板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1175448508","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175448508?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:23","pubTimestamp":1788769386,"startTime":"0","endTime":"0","summary":"0727 GMT——CGS国际分析师Kasem Prunratanamala在研报中指出,Klinique医疗诊所上调了2026年营收指引,但这一利好消息似乎已被市场提前消化。这家医疗美容诊所运营商将2026年营收目标从41.5亿泰铢上调至45亿泰铢,理由是7月份现金销售增长强劲。尽管公司运营势头稳健,同店销售增长韧性十足,但近期股价的强势表现已充分反映了大部分正面消息。该券商维持该股\"持有\"评级及28.00泰铢的目标价。目前股价报29.00泰铢,上涨1.75%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4581","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折,令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病,系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据,预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试,这些试验依赖于确诊的心脏相关事件,且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","LLY","LLII","JDOC","FHLC","CANC","PJP","IBB","LU2324357040.USD","IYH","NAMS","PPH","CURE","ELIL","LU0456855351.SGD","GDOC","TMED","IE00BK4W5L77.USD","LU1988902786.USD","VHT","PBE","FTXH","LU2491049909.HKD","BIB","IHE","ELIS","LLYZ","TBXU","ILDR","SLN","AGNG","LU1551013425.SGD","LU2746668974.SGD","AMGN","THNR","LU0096364046.USD","IBBQ","BBH","BK4588","MHIP","XLV","MEDX","MEDI","TRUH","WDNA","BK4581","RXL","OZEM","HRTS","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665954553","title":"人保健康保險大連分公司被罰27萬,涉聘任不合格人員等","url":"https://stock-news.laohu8.com/highlight/detail?id=2665954553","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665954553?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:47","pubTimestamp":1788749245,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月7日讯,近日,国家金融监督管理总局大连监管局发布行政处罚决定书,剑指中国人民健康保险股份有限公司大连分公司及相关责任人。罚单显示,中国人民健康保险股份有限公司大连分公司的主要违法违规行为是:聘任不具有任职资格的人员;编制、提供虚假的报告报表文件资料。针对上述违法行为,国家金融监督管理总局大连监管局对中国人民健康保险股份有限公司大连分公司罚款27万元;对傅信弘警告,罚款7万元;对周笑俊警告,罚款7万元;对刘志东警告,罚款1万元;对李翔警告,罚款4万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788746879733984657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LABU","XLV","BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665561483","title":"研究發現,美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现,美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示,由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法,自2019年以来,美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童,结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","SG9999013999.USD","LU1366192091.USD","LU2063271972.USD","LU2112291526.USD","BK4599","IE00BK4W5L77.USD","LU2750360997.AUD","SG9999018865.SGD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU1280957306.USD","ELIS","LU2023250504.SGD","LU1868836591.USD","LU1979441026.SGD","LU0079474960.USD","LLYZ","LU0203202063.USD","LU0256863902.USD","LU1064131342.USD","LU1988902786.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU1323610961.USD","BK4581","LU2237443978.SGD","IE0004445015.USD","LU0683600562.USD","FHLC","LU2168564495.EUR","LU1551013425.SGD","LU2361044865.SGD","MEDX","LU2324357040.USD","MHIP","LU2237443465.HKD","BK4516","GB00BDT5M118.USD","IE0004445239.USD","LU1712237335.SGD","LU0133085943.USD","LU1720051108.HKD","SG9999014906.USD","LU2491050071.SGD","SGXZ57979304.SGD","RXL","LLY","IE0002141913.USD","BK4534","LU0882574055.USD","IE00BJLML261.HKD","LU2361045086.USD","LU2756315318.SGD","ELIL","LU0210536198.USD","LU2237443895.HKD","LU1145028129.USD","LU2237443382.USD","LU1267930730.SGD","LU2462591350.SGD","XLV","LU2108987350.USD","CURE","NVOC","OZEM","LU2211815571.USD","IE00BKPKM429.USD","LU2168564065.EUR","LU2089984988.USD","LU1974910355.USD","GDOC","LU2746668461.USD","LU2271345857.HKD","IHE","LU1804176565.USD","LU2023250330.USD","LU0174119429.USD","SG9999017495.SGD","LU0471298777.SGD","LU2168564149.EUR","TMED","LU1551013342.USD","LU0158827948.USD","BK4007","VHT","LU0266013472.USD","LU0006306889.USD","SG9999001176.USD","SG9999014880.SGD","LU0114720955.EUR","LU0417517546.SGD","LU1232071149.USD","LU2213496289.HKD","SGXZ31699556.SGD","LU0471298694.HKD","JDOC","SG9999015986.USD","IE00BJJMRY28.SGD","MEDI","NVOH","LU0456855351.SGD","LU0820561909.HKD","LU2028103732.USD","LU0889565916.HKD","SG9999014914.USD","SGXZ51526630.SGD","LU0820562030.AUD","LU2468319806.SGD","LU2471134952.CNY","LU2236285917.USD","IYH","LU0158827781.USD","LU0320765059.SGD","PJP","LU2750360641.GBP","LU1023059063.AUD","LU1989771016.USD","LU2168564222.USD","IE00BN29S564.USD","LU1093756168.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","THNR","SGXZ81514606.USD","LU0234572021.USD","SG9999015978.USD","LU2089284900.SGD","LLII","IE00B1XK9C88.USD","LU1691799644.USD","LU0353189763.USD","LU1061106388.HKD","IE00BWXC8680.SGD","LU2417539215.USD","NVO","LU1868837136.USD","IE00BFSS8Q28.SGD","LU0353189680.USD","LLYX","LU0122379950.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","IE00BZ1G4Q59.USD","LU1548497426.USD","SG9999014898.SGD","BK4585","IE0001KFT4U8.USD","LU0354030438.USD","LU0786609619.USD","LU1814569148.SGD","LU2552382215.SGD","LU2491050154.USD","LU0316494557.USD","LU0823434583.USD","BK4532","CANC","LU1069344957.HKD","LU2168563687.JPY","LU0097036916.USD","NVOX","IE00B4JS1V06.HKD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","LU0640476718.USD","LU0432979614.USD","WDNA","LU0154236417.USD","LU2237443622.USD","SGXZ99366536.SGD","LU1868837300.USD","LU1093756325.SGD","LU0094547139.USD","LU0109394709.USD","LU2023251221.USD","LU2552382132.HKD","SG9999015952.SGD","LU0823434740.USD","LU2237443549.SGD","LU0289739699.SGD","LU1720051017.SGD","LU0466842654.USD","LU0964807845.USD","LU0943347566.SGD","LU1868836757.USD","LU0238689110.USD","LU0320765992.SGD","LU0096364046.USD","LU0354030511.USD","LU0672654240.SGD","LU2361044949.HKD","IE0005OL40V9.USD","LU2357305700.SGD","LU2456880835.USD","LU0323591593.USD","LU0106261372.USD","LU2089283258.USD","IE00B1BXHZ80.USD","BK4588","FTXH","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","LU2491049909.HKD","PPH","IXJ","LU0820561818.USD","LU2265009873.SGD","LU2461242641.AUD","LU1035775433.USD","IE00BK4W5M84.HKD","LU0225283273.USD","LU1917777945.USD","TRUH","LU0058720904.USD","LU1057294990.SGD","LU2106854487.HKD","AGNG","LU1868836914.USD","LU2552382058.USD","LU1983299246.USD","SG9999001176.SGD","LU1623119135.USD","LU2602419157.SGD","IE00B775H168.HKD","LU0198837287.USD","LU2111349929.HKD","BK4533","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU2471134523.USD","LU2471134879.HKD","LU0109391861.USD","LU0823416689.USD","LU0787776722.HKD","LU1629891620.HKD","LU0345770993.USD","LU2087625088.SGD","SG9999018857.SGD","LU2746668974.SGD","IE0009355771.USD","LU0256863811.USD","SG9999015945.SGD","LU2237438978.USD","LU2360106947.USD","ILDR","LU1291159041.SGD","LU2896262040.SGD","LU0345770308.USD","HRTS","LU0203201768.USD","LU2471134796.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136673456","title":"醫療健康板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1136673456","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136673456?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 00:24","pubTimestamp":1788539073,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场快讯已经发布,仅在道琼斯通讯社平台独家呈现,更新时段分别为美东时间凌晨4:20、中午12:20及下午4:50。分析师们认为,此项交易、上半年销售势头以及中国监管机构另行批准的进展,或将显著提升市场对和黄医药业绩指引的可见度。该公司预计2026年肿瘤学与免疫学领域收入将在3.3亿至4.5亿美元之间。目前该公司股价报22.60港元,涨幅为3.3%。以太坊上涨4.7%至2,506美元,瑞波币攀升7.4%至1.45美元,Solana则上涨4.8%至104.45美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334816","title":"丹陽家長注意!2027年度學生醫保繳費啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334816","media":"丹阳发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334816?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:05","pubTimestamp":1788523500,"startTime":"0","endTime":"0","summary":"为充分保障在校学生的医疗保险待遇,丹阳市2027年度学生参加城乡居民医疗保险的参保登记工作由学校统一为学生办理,个人缴费标准为450元,长期护理保险根据国家规定暂不单独筹资。被认定为资助参保救助对象的学生,可以选择参加认定地基本医疗保险,丹阳市救助学生个人缴费部分由社会医疗救助基金承担,个人无需缴费。同一年度第二次住院,起付标准按相应医疗机构级别标准降低50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-04/doc-iniqskun4096571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4588","XBI","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380422","title":"一項針對僱主的調查預計,美國醫療保健成本將出現20多年來最大漲幅:2027年僱主提供的醫療保險成本預計將較今年上升8.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380422","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664380422?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:43","pubTimestamp":1788511437,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4581","BK4585","XLV","MHIG","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161674237","title":"醫療板塊市場快訊:和黃醫藥與GSK達成許可協議,AstraZeneca新藥前景獲看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1161674237","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161674237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:22","pubTimestamp":1788510155,"startTime":"0","endTime":"0","summary":"花旗分析师在报告中指出,和黄医药与葛兰素史克达成的合作协议,实际上是对这家总部位于香港的生物制药公司某一特定候选药物平台的价值背书——尽管该药物尚未进入临床试验阶段。此番和黄医药与GSK签署的授权协议,在剔除净销售额特许权使用费后,潜在交易总额最高可达12.95亿美元,标的为一种癌症治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388058","title":"109億美元重磅收購Apogee(APGE.US)落地!艾伯維(ABBV.US)完成2019年以來最大併購,預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4533","FTXH","JDOC","RXL","APGE","LU0234570918.USD","LU0114720955.EUR","GLAM","LU2237443549.SGD","SG9999003800.SGD","IE0002141913.USD","IYH","PPH","LU1236620834.HKD","CALF","FHLC","LU2125909593.SGD","LU2087621335.USD","KCE","LU0124676726.USD","IE00B19Z3B42.SGD","LU0203345920.USD","SBIO","LU0820561909.HKD","AGNG","TRUH","LU2433249047.HKD","XMMO","LU0310800379.SGD","LU2237443895.HKD","MYLD","PJP","LU2129689514.USD","LU0170899867.USD","LU2129689605.HKD","IE000WAW04H5.SGD","LU0128525929.USD","LU1839511570.USD","LU1496350502.SGD","VHT","LU0069063385.USD","LU2089984988.USD","MEDX","IXJ","LU1551013425.SGD","LU1267930490.SGD","ABBV","LU0320765646.SGD","XLV","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664053388","title":"109億美元重磅收購Apogee(APGE.US)落地!艾伯維(ABBV.US)完成2019年以來最大併購,預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664053388","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664053388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,艾伯维于周四表示,公司已完成对抗炎药物研发商 Apogee Therapeutics价值 109 亿美元的收购。笔交易是这家制药巨头自 2019 年以来规模最大的补强型收购,智通财经AAPP于今年 6 月首次对此进行了报道。艾伯维预计,该项收购将对其调整后稀释每股收益产生负面影响,其中 2026 年将减少 0.14 美元,2027 年减少约 0.46 美元,并预计将于 2032 年开始实现增益。该指引已包含与完成 Apogee 收购相关的每股 0.14 美元稀释效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0124676726.USD","IXJ","KCE","GLAM","IE00B2B36J28.USD","LU0256863902.USD","LU1989772840.SGD","VHT","FTXH","LU1934455194.USD","LU1718418525.SGD","RXL","IE00BN8TJ469.HKD","FHLC","APGE","IE00BLSP4239.USD","LU0057025933.USD","LU0289739343.SGD","LU2089283258.USD","IE0002270589.USD","LU2237443549.SGD","XLV","LU0203345920.USD","CALF","BK4559","LU1236620834.HKD","MEDX","IE00B4R5TH58.HKD","LU1003077747.HKD","LU0985320562.USD","TRUH","BK4581","BK4566","IYH","LU0170899867.USD","SG9999011175.SGD","IE0004445239.USD","XMMO","LU1983299246.USD","MYLD","PJP","LU0965509283.SGD","LU1093756168.USD","LU1037948541.HKD","PPH","SBIO","IE00B19Z3581.USD","ABBV","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664496800","title":"默沙東PD-1抑制劑可瑞達局部晚期頭頸鱗癌適應症在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2664496800","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664496800?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 08:43","pubTimestamp":1788482626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0070302665.USD","SG9999014567.USD","LU1035773651.USD","LU0266013472.USD","IE00BN8TJ469.HKD","IYH","LU0006306889.USD","LU0965508806.USD","LU1162221912.USD","LU2089984988.USD","LU1069347547.HKD","LU0208291251.USD","LU1291159041.SGD","IHE","LU2461242641.AUD","LU0203345920.USD","LU1923622614.USD","LU1066051498.USD","LU2433249047.HKD","LU0238689110.USD","LU2023250504.SGD","LU2125154935.USD","LU0965509010.AUD","LU1037948897.HKD","LU1201861249.SGD","LU1989771016.USD","LU2361044865.SGD","TRUH","LU1974910355.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","SG9999015341.SGD","LU1699723380.USD","LU2491050154.USD","FTXH","BK4559","LU0823416689.USD","LU1983299246.USD","LU1023059063.AUD","LU1941712264.USD","LU1116320901.HKD","SG9999001176.SGD","GDOC","LU2361044949.HKD","LU1585245621.USD","LU0234572021.USD","LU2491049909.HKD","LU0130517989.USD","PAWZ","LU0648001328.SGD","LU0320765489.SGD","BMED","VHT","LU2023250843.SGD","LU2361045086.USD","LU1093756325.SGD","RXL","IE00B4R5TH58.HKD","LU0320765646.SGD","LU2125909593.SGD","LU2360032135.SGD","LU0965509283.SGD","LU0965509101.SGD","IE0002141913.USD","LU0980610538.SGD","LU1057294990.SGD","IE00B2B36J28.USD","LU1989772923.USD","IE00BLSP4239.USD","BK4550","LU1116320737.USD","IXJ","BK4533","LU0985320562.USD","LU1430594728.SGD","LU0211331839.USD","SG9999014575.USD","LU2324357040.USD","HRTS","BK4534","LU1037948541.HKD","LU1929549753.HKD","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00B1BXHZ80.USD","PPH","XLV","LU1066051811.HKD","LU2125909247.SGD","SG9999014542.SGD","LU0130102774.USD","LU0868494708.USD","LU0265550946.USD","BK4588","SG9999001440.SGD","LU1941712348.USD","BK4007","LU1032466523.USD","BK4585","LU1934455277.USD","LU0861579265.USD","BK4516","JDOC","LU1061106388.HKD","SG9999002224.SGD","SG9999015358.SGD","LU0859254822.USD","LU1989772840.SGD","FHLC","SG9999002232.USD","LU0098860793.USD","LU0942090050.USD","LU2125154778.USD","LU1934455863.HKD","LU0124676726.USD","LU0432979614.USD","LU0477156953.USD","SG9999001176.USD","LU2112291526.USD","LU0058720904.USD","LU1093756168.USD","LU1066051225.USD","LU0689626769.HKD","SG9999013999.USD","IE00BBT3K403.USD","IE0009355771.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU2468319806.SGD","LU1917777945.USD","MRK","LU0106261372.USD","IE00BLSP4452.SGD","LU2491050071.SGD","SG9999014559.SGD","LU0122379950.USD","LU0265550359.USD","LU1934455194.USD","LU2106854487.HKD","LU0868494617.USD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154879404","title":"醫療保健板塊市場快訊:比特幣漲勢帶動加密市場樂觀情緒,阿斯利康新藥潛力引關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1154879404","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154879404?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 04:58","pubTimestamp":1788469126,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健板块市场快讯已发布,涵盖多家重要企业的动态与分析师观点。比特币自8月以来的上涨走势,为加密货币市场注入了乐观情绪。\"目前,比特币已突破8万美元大关,最新报81,054美元,涨幅达4.7%。\"阿斯利康股价上涨1.5%。在英国市场,一项重大新合同的整合延迟以及劳动力成本正在拖累业绩表现。\"Jefferies维持对Sonic的持有评级,目标价定为每股21.00澳元,该股周三收于18.73澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188599563","title":"醫療健康板塊市場綜述:行業動態與個股追蹤","url":"https://stock-news.laohu8.com/highlight/detail?id=1188599563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188599563?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 00:22","pubTimestamp":1788452559,"startTime":"0","endTime":"0","summary":"0810 GMT——Berenberg分析师在研究报告中指出,阿斯利康治疗慢性阻塞性肺病的新药若能在所有患者群体中展现出有效性,有望成为该领域的市场领军者。这家英国药企今年早些时候公布的初期试验结果显示,托佐利单抗在既往吸烟者的主要人群及整体人群中均带来了获益,且在不同肺功能阶段皆展现疗效。Berenberg表示:“我们认为减少30%的急性加重将是一个极为积极的结果,且超出预期。”该公司股价上涨1.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664808013","title":"印度西普拉(Cipla)與中國齊魯製藥合作,在美國推出默克公司Keytruda的生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664808013","media":"路透中文","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664808013?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 23:24","pubTimestamp":1788449052,"startTime":"0","endTime":"0","summary":"印度西普拉与中国齐鲁制药合作,在美国推出默克公司Keytruda的生物类似药路透9月3日-印度西普拉公司周四表示,其美国子公司与中国齐鲁制药达成独家合作协议,获得默克公司抗癌药物“Keytruda”生物类似药在美国市场的授权。详情如下:根据协议,齐鲁制药将负责对QL2107的研发、监管审批、生产和供应,而CiplaUSA将负责该药在美国的商业化及销售。默克公司持有的“Keytruda”专利保护将于2028年到期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4T44V1B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU0203345920.USD","LU2461242641.AUD","PAWZ","PPH","LU1430594728.SGD","LU1983299246.USD","IE00BSNM7G36.USD","IYH","IE00BLSP4452.SGD","LU1989772840.SGD","LU1934455194.USD","LU1585245621.USD","LU0122379950.USD","IE00B1BXHZ80.USD","LU2433249047.HKD","SG9999001440.SGD","LU0006306889.USD","LU0070302665.USD","LU1061106388.HKD","LU2491050154.USD","LU0211331839.USD","LU0058720904.USD","BK4585","IE00BBT3K403.USD","LU0098860793.USD","MRK","LU1032466523.USD","LU1989771016.USD","LU2361045086.USD","LU1093756325.SGD","XLV","LU1162221912.USD","LU2023250504.SGD","LU2468319806.SGD","SG9999014542.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4516","SG9999013999.USD","LU0265550946.USD","LU0823416689.USD","BK4533","TRUH","LU0980610538.SGD","LU0965509010.AUD","LU0942090050.USD","VHT","LU2106854487.HKD","IE000M9KFDE8.USD","LU2357627491.SGD","LU0965509101.SGD","SG9999001176.SGD","LU2324357040.USD","LU1571399168.USD","LU1934455277.USD","LU2125909593.SGD","LU1066051811.HKD","LU1974910355.USD","BK4550","LU0965509283.SGD","HRTS","LU1069347547.HKD","LU1066051498.USD","LU1917777945.USD","LU0289739699.SGD","LU0320765646.SGD","CPLFY","LU2491050071.SGD","LU0238689110.USD","LU1941712264.USD","LU2112291526.USD","LU0868494617.USD","SG9999014567.USD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0648001328.SGD","LU0130102774.USD","LU0130517989.USD","JDOC","IE00BN8TJ469.HKD","LU0234572021.USD","RXL","LU0965508806.USD","LU0689626769.HKD","LU0868494708.USD","LU2361044949.HKD","LU1037948897.HKD","BK4559","LU1923622614.USD","LU1934455863.HKD","LU0106261372.USD","SG9999015358.SGD","IE00BLSP4239.USD","BMED","FHLC","IHE","LU1699723380.USD","LU0124676726.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","IXJ","LU0477156953.USD","IE0009355771.USD","LU1989772923.USD","LU1929549753.HKD","IE00B2B36J28.USD","LU2361044865.SGD","LU0859254822.USD","LU0320765489.SGD","LU2023250843.SGD","SG9999014575.USD","LU1116320901.HKD","LU2491049909.HKD","LU0985320562.USD","LU1201861249.SGD","BK4534","LU2125909247.SGD","LU2360032135.SGD","LU0203347892.USD","LU0265550359.USD","SG9999002224.SGD","LU1037948541.HKD","LU0432979614.USD","LU1093756168.USD","LU1291159041.SGD","LU1941712348.USD","SG9999015341.SGD","BK4007","LU0861579265.USD","LU1066051225.USD","BK4588","LU0266013472.USD","LU2125154935.USD","SG9999001176.USD","LU1116320737.USD","LU1023059063.AUD","FTXH","IE00BJJMRZ35.SGD","SG9999014559.SGD","LU2125154778.USD","GDOC","LU1057294990.SGD","SGXZ57979304.SGD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877326","title":"美國衞生與公眾服務部醫療保險和醫療補助服務中心:特朗普政府宣佈撥款1.2億美元,用於擴大印第安納州母嬰健康服務,提高初級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:22","pubTimestamp":1788441723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","SG9999014021.USD","LU0320765489.SGD","LU0070302665.USD","BK4566","HUM","LU1983260115.SGD","RSPH","LABU","BK4533","LU0348723411.USD","LU0238689110.USD","LU1093756325.SGD","LU0208291251.USD","FXH","LU0266013472.USD","BK4154","LU0211331839.USD","LU0256863811.USD","SG9999014005.SGD","LU1093756168.USD","BK4585","LU0417517546.SGD","BK4588","SG9999014013.SGD","LU0170899867.USD","XLV","BK4581","LU0390134368.USD","IHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112455320","title":"艾伯維公布Cervino三期試驗積極頂線結果:Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1112455320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112455320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:19","pubTimestamp":1788441558,"startTime":"0","endTime":"0","summary":"艾伯维公司今日宣布,其针对复发或难治性多发性骨髓瘤患者的关键性Cervino三期临床试验,取得了积极的顶线数据。研究结果显示,在研药物Etentamig不仅显著提高了患者的客观缓解率,更在延长无进展生存期方面展现出压倒性的统计学优势。Cervino试验是一项全球性的、随机、开放标签的注册研究,旨在评估Etentamig相较于标准治疗的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU2129689514.USD","LU0198837287.USD","LU1718418525.SGD","SG9999003800.SGD","PPH","LU1267930490.SGD","LU1074936037.SGD","LU1003077747.HKD","IE0002270589.USD","LU1430594728.SGD","LU1983299246.USD","IE00BSNM7G36.USD","IYH","IE00BLSP4452.SGD","LU1989772840.SGD","LU2237443549.SGD","LU0472753341.HKD","MEDX","LU1934455194.USD","LU1585245621.USD","LU0122379950.USD","IE000MB6IJN5.SGD","LU0726765562.USD","LU1670627923.USD","LU2433249047.HKD","BK4581","SG9999001440.SGD","LU1244550577.SGD","LU0795875169.SGD","SG9999015952.SGD","IE00BGHQF631.EUR","LU0708994859.HKD","LU1061106388.HKD","LU0058720904.USD","LU0158827948.USD","BK4585","IE00BBT3K403.USD","LU0098860793.USD","LU0211327993.USD","IE00B19Z3581.USD","AGNG","SG9999015986.USD","LU1989771016.USD","IE0000B7K699.USD","LU2129689605.HKD","LU1093756325.SGD","XLV","LU1162221912.USD","BK4139","LU2133065610.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU1839511570.USD","IE00BVYPNW00.USD","LU2089284900.SGD","LU0289739343.SGD","LU1244550494.USD","IE0002141913.USD","BK4566","LU0823416689.USD","BK4533","LU1496350171.SGD","TRUH","LU0965509010.AUD","LU0511384066.AUD","LU0942090050.USD","LU0820561818.USD","SG9999015945.SGD","VHT","LU1551013425.SGD","LU2357627491.SGD","SG9999015978.USD","LU0965509101.SGD","LU1934455277.USD","LU2125909593.SGD","LU0949170772.SGD","BK4550","LU0965509283.SGD","LU0661504455.SGD","LU0256863811.USD","LU1267930573.SGD","GLAM","IE000WAW04H5.SGD","LU0545039389.USD","LU0289739699.SGD","LU2129689431.USD","LU1732800096.USD","LU0320765646.SGD","LU0795875086.SGD","LU1732799900.SGD","LU0912757837.SGD","LU2112291526.USD","LU0868494617.USD","LU0114720955.EUR","LU2089984988.USD","IE00B4R5TH58.HKD","IE000BZT7R73.USD","LU0553294199.USD","LU2237443622.USD","LU0417517546.SGD","LU0310800379.SGD","ABBV","LU0256863902.USD","LU2347655073.USD","LU0069063385.USD","IE00B3PB1722.GBP","JDOC","IE00BN8TJ469.HKD","LU0234572021.USD","RXL","LU0965508806.USD","LU0689626769.HKD","LU0868494708.USD","LU1037948897.HKD","BK4559","LU1923622614.USD","LU0456855351.SGD","LU1934455863.HKD","IE00BLSP4239.USD","LU2087621335.USD","FHLC","LU0820561909.HKD","IE00BVYPNV92.GBP","LU0882574055.USD","LU0124676726.USD","LU0128525929.USD","LU1236620834.HKD","LU2237443895.HKD","LU0395794307.EUR","PJP","IE00BFTCPJ56.SGD","LU2023251221.USD","IXJ","LU0738911758.USD","LU0289961442.SGD","IE0009355771.USD","LU2237443465.HKD","LU1244550221.USD","LU1989772923.USD","LU1929549753.HKD","IE00B2B36J28.USD","LU0859254822.USD","SG9999011175.SGD","LU2089283258.USD","LU0985320562.USD","BK4534","LU2125909247.SGD","IE00B42XCP33.USD","LU0203347892.USD","LU1037948541.HKD","LU0432979614.USD","LU1093756168.USD","LU1291159041.SGD","LU0029864427.USD","LU1670628061.USD","LU1236620750.USD","LU2237443382.USD","LU2237443978.SGD","LU0861579265.USD","LU1551013342.USD","LU0310799852.SGD","LU0943347566.SGD","BK4588","LU0057025933.USD","LU0234570918.USD","IE0004445239.USD","LU0170899867.USD","IE000SO60NU8.SGD","LU1023059063.AUD","LU0211328371.USD","FTXH","IE00BJJMRZ35.SGD","LU1496350502.SGD","IE000F7OJYX1.SGD","LU2347655156.SGD","LU1057294990.SGD","IE00BDGV0183.EUR","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287786","title":"艾伯維的血液癌症藥物達到了晚期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441535,"startTime":"0","endTime":"0","summary":"艾伯维的血液癌症药物达到了晚期临床试验的目标路透9月3日-艾伯维(AbbVie)ABBV.N周四表示,其用于治疗某类血液癌症的药物已达到一项晚期临床试验的主要目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4T44V12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LU1732800096.USD","LU0795875169.SGD","LU0942090050.USD","SG9999011175.SGD","LU2125909593.SGD","LU2237443382.USD","LU1244550494.USD","LU1934455194.USD","PJP","IE00B2B36J28.USD","LU0170899867.USD","LU0289961442.SGD","IE00B19Z3B42.SGD","SG9999001440.SGD","ABBV","LU2089283258.USD","LU1430594728.SGD","LU0511384066.AUD","GLAM","IE000WAW04H5.SGD","VHT","FHLC","IXJ","BK4588","LU0456855351.SGD","LU1093756325.SGD","LU0545039389.USD","LU1989771016.USD","FTXH","JDOC","LU0861579265.USD","TRUH","XLV","LU1934455863.HKD","RXL","IE00BBT3K403.USD","LU0128525929.USD","IE00B3PB1722.GBP","IYH","LU2237443465.HKD","MEDX","PPH","LU1244550577.SGD","LU1839511570.USD","SG9999003800.SGD","SG9999015945.SGD","LU0234572021.USD","LU0859254822.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874779","title":"阿斯彭預計,2027年Mounjaro在非洲的銷售額將超過1.24億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874779","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874779?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 20:37","pubTimestamp":1788439031,"startTime":"0","endTime":"0","summary":"阿斯彭预计,2027年Mounjaro在非洲的销售额将超过1.24亿美元阿斯彭已向肯尼亚和尼日利亚提交了Mounjaro的注册申请截至6月底的这一年度内,南非GLP-1市场规模几乎翻倍,达到28亿兰特阿斯彭计划在部分市场推出奥兹莫皮克仿制药,巴西也在其中Nqobile Dludla路透约翰内斯堡9月3日-阿斯彭制药预计,在南非需求激增以及计划在尼日利亚和肯尼亚上市的推动下,礼来公司旗下LLY.N这款重磅减肥及糖尿病药物Mounjaro在本财年的非洲销售额将超过20亿兰特。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4S44V0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","IE00BN29S564.USD","LU1989771016.USD","HRTS","LU1069344957.HKD","LU0683600562.USD","LU1291159041.SGD","FTXH","LU2087625088.SGD","SG9999013999.USD","LU0109394709.USD","FHLC","LLY","LU1267930730.SGD","SG9999015952.SGD","OZEM","CURE","LU0323591593.USD","LU2237443549.SGD","IE00B775H168.HKD","IE00BK4W5L77.USD","LU1280957306.USD","LU2461242641.AUD","LU0266013472.USD","IE00B4R5TH58.HKD","LU1804176565.USD","ELIL","XLV","LU0256863811.USD","LU0354030438.USD","LU2462157665.USD","SGXZ99366536.SGD","LU2552382058.USD","LU0109391861.USD","LU2237438978.USD","LU2111349929.HKD","LU0640476718.USD","SG9999014880.SGD","BK4534","LU1548497426.USD","LU2089984988.USD","LU2106854487.HKD","IE00BJT1NW94.SGD","LU2750360997.AUD","LU1145028129.USD","LU1023059063.AUD","IE0005OL40V9.USD","LU2491049909.HKD","LU0079474960.USD","LU1093756168.USD","SG9999014898.SGD","LU1988902786.USD","LU0820561818.USD","LU1868836914.USD","JDOC","LU2552382132.HKD","LU2211815571.USD","LU2236285917.USD","BK4585","LU2491050154.USD","PJP","IE00B7KXQ091.USD","LU2023251221.USD","GB00BDT5M118.USD","PPH","LU1720051017.SGD","LU2213496289.HKD","LU0882574139.USD","TRUH","LU2361044865.SGD","SG9999018857.SGD","IE0009355771.USD","SG9999001176.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1629891620.HKD","LU2896262040.SGD","GDOC","LU2756315664.SGD","RXL","LU0256863902.USD","LU0385154629.USD","BK4588","LU0114720955.EUR","LU2417539215.USD","LU0466842654.USD","SG9999015945.SGD","LU0210536198.USD","BK4516","LU2237443895.HKD","LU2750360641.GBP","LU0354030511.USD","LU0158827948.USD","LU2361045086.USD","MEDI","LU2552382215.SGD","IE00BJLML261.HKD","LU0708995401.HKD","LU0820562030.AUD","LU0471298777.SGD","SG9999014906.USD","SGXZ81514606.USD","IE00BK4W5M84.HKD","LU2471134796.USD","IHE","LU2168564495.EUR","LU1974910355.USD","LU2168564065.EUR","LU2468319806.SGD","LU2028103732.USD","LU0158827781.USD","SG9999001176.SGD","LU0106261372.USD","LU1691799644.USD","LU2357305700.SGD","TMED","LU1551013425.SGD","LU2491050071.SGD","LU2089283258.USD","LU2324357040.USD","LU2108987350.USD","LU0122379950.USD","LU0943347566.SGD","APNHY","LU2264538146.SGD","LU0353189680.USD","SG9999017495.SGD","LU0096364046.USD","IE00BKPKM429.USD","LU1712237335.SGD","LU2089284900.SGD","LU1979441026.SGD","LU0471298694.HKD","LU2360106947.USD","IE00BJJMRZ35.SGD","LU2168563687.JPY","LU2746668461.USD","LU1035775433.USD","LU0006306889.USD","LU0061475181.USD","LU1814569148.SGD","LU2471134523.USD","LU0432979614.USD","LU1127390331.HKD","SGXZ57979304.SGD","LU0320765059.SGD","LU1061106388.HKD","IE0001KFT4U8.USD","LU2237443382.USD","IE00B2B36J28.USD","LU0174119429.USD","SG9999018865.SGD","SG9999014914.USD","LU2023250504.SGD","LU0345770993.USD","LU2271345857.HKD","LU0889565916.HKD","ILDR","BK4599","LU0316494557.USD","LU0417517546.SGD","LU0133085943.USD","LU0058720904.USD","LU0203201768.USD","LU1057294990.SGD","LU0823434740.USD","LU2168564222.USD","SGXZ51526630.SGD","IE00B1BXHZ80.USD","LU0225283273.USD","LU2602419157.SGD","VHT","LU0456855351.SGD","LU0689472784.USD","LU0787776722.HKD","LU1868837136.USD","LU2361044949.HKD","LU1551013342.USD","THNR","LU0345770308.USD","LU0823416689.USD","LU2471134952.CNY","IE00BFSS7M15.SGD","LLYX","IE0004445239.USD","LU0097036916.USD","IE0002141913.USD","LU1064131342.USD","LU0672654240.SGD","LU1868837300.USD","LU2023250330.USD","MEDX","AGNG","IE00B1XK9C88.USD","LU0094547139.USD","LU0964807845.USD","MHIP","BK4533","LU0289739699.SGD","LU2746668974.SGD","LU1623119135.USD","LU2237443622.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU0823434583.USD","LU1983299246.USD","IE00B4JS1V06.HKD","LU2462591350.SGD","WDNA","BK4581","LLII","IE00BKDWB100.SGD","LU0353189763.USD","IE00BJJMRX11.SGD","LU0238689110.USD","LU0820561909.HKD","IE00BWXC8680.SGD","IE00BFSS8Q28.SGD","IXJ","LU1868836591.USD","LU1917777945.USD","LU1868836757.USD","SG9999015986.USD","LU1323610961.USD","LU2237443978.SGD","LU2237443465.HKD","LU2456880835.USD","LU2756315318.SGD","LU2265009873.SGD","LU0203202063.USD","LU2471134879.HKD","LU0198837287.USD","CANC","LU0786609619.USD","LU2063271972.USD","LU2112291526.USD","LU1232071149.USD","BK4007","LU0320765992.SGD","LU0882574055.USD","LU1366192091.USD","SG9999015978.USD","IE00BJJMRY28.SGD","IE0004445015.USD","IYH","ELIS","LU2168564149.EUR","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664791008","title":"American Healthcare REIT(AHR)宣佈完成收購八個高端養老社區 涉資近7億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664791008","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664791008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:17","pubTimestamp":1788434240,"startTime":"0","endTime":"0","summary":"金吾财讯 | American Healthcare REIT 宣布以约6.96亿美元的总价收购了八个A级高端老年住宅社区,一举打入供应受限的美国东北部养老地产核心市场。据悉,AHR在完成交易后,将另外两项非核心社区的购买协议以成本价转让给了另一家机构投资者。而随着本次收购落地,AHR在2026年年内完成的总投资额已突破20亿美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JJJ.SI","AHR","MDIV","SRT.SI","BK4588","YLDW","BK4581","BPRE","XBI","RNTY","BK6142","SRU.SI","8C8U.SI","CFA.SI","XLV","CLR.SI","RJMG","BK4225","BK4585","LABU","DFRA","PSCF","GLS.SI","IQRA","IVRA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}